These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 20063208)

  • 1. Scleroderma lung disease.
    Le Pavec J; Launay D; Mathai SC; Hassoun PM; Humbert M
    Clin Rev Allergy Immunol; 2011 Apr; 40(2):104-16. PubMed ID: 20063208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and management approaches for scleroderma lung disease.
    Schoenfeld SR; Castelino FV
    Ther Adv Respir Dis; 2017 Aug; 11(8):327-340. PubMed ID: 28621173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lung involvement in systemic sclerosis].
    Posa M; Stelle M; Lador F; Chizzolini C
    Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary arterial hypertension associated with systemic sclerosis.
    Mathai SC; Hassoun PM
    Expert Rev Respir Med; 2011 Apr; 5(2):267-79. PubMed ID: 21510736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging lung disease in systemic sclerosis.
    Strollo D; Goldin J
    Curr Rheumatol Rep; 2010 Apr; 12(2):156-61. PubMed ID: 20425026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis].
    Legendre P; Mouthon L
    Rev Prat; 2017 Sep; 67(7):775-783. PubMed ID: 30512777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.
    Sankar S; Habib M; Jaafar S; Nagaraja V; Roofeh D; Young A; Huang S; Khanna D
    Clin Exp Rheumatol; 2021; 39 Suppl 131(4):43-51. PubMed ID: 33734968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort.
    Vemulapalli S; Cohen L; Hsu V
    Scand J Rheumatol; 2017 Jul; 46(4):281-287. PubMed ID: 27635465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Launay D; Sobanski V; Hachulla E; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis-associated interstitial lung disease.
    Perelas A; Silver RM; Arrossi AV; Highland KB
    Lancet Respir Med; 2020 Mar; 8(3):304-320. PubMed ID: 32113575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
    Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
    Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.
    Mangat P; Conron M; Gabbay E; Proudman SM;
    Intern Med J; 2010 Jul; 40(7):494-502. PubMed ID: 19460060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological, clinical and evolutionary peculiarities of interstitial lung disease in systemic sclerosis].
    Aydi Z; Rachdi I; Ben Dhaou B; Dridi M; Daoud F; Baili L; Boussema F
    Rev Pneumol Clin; 2016 Apr; 72(2):122-8. PubMed ID: 26651932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
    Swartz JS; Chatterjee S; Parambil JG
    J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Haque A; Kiely DG; Kovacs G; Thompson AAR; Condliffe R
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34407977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring and Diagnostic Approaches for Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis.
    Valenzuela A; Nandagopal S; Steen VD; Chung L
    Rheum Dis Clin North Am; 2015 Aug; 41(3):489-506. PubMed ID: 26210131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of impairment in lung diffusing capacity in patients with systemic sclerosis.
    Guarnieri G; Zanatta E; Mason P; Scarpa MC; Pigatto E; Maestrelli P; Cozzi F
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S80-6. PubMed ID: 25897784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
    Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
    J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.